ALS is a neurodegenerative disease driven by inflammation, excitotoxicity, and mitochondrial failure. A multimodal protocol—HBOT, PBM, VL-rTMS, ketogenic nutrition, hydrogen water, and supportive therapies—aims to improve energy, comfort, and slow functional decline without curing the disease.
Read More2 min read